Prestige Consumer (PBH) | Stock Overview & Key Data
Prestige Consumer Performance Comparison
Stock Range
Today's Range
Low: $64.68
High: $65.85
on August 15, 2025
52 Week Range
Low: $62.95
High: $90.04
on August 12, 2025
on March 10, 2025
All-Time High: $90.04 on March 10, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$3.8B
EPS
4.29
P/E Ratio (TTM)
17.92
Forward P/E
16.12
P/B Ratio
2.07
PEG Ratio
16.12
Div. Yield
N/A
ROE
12.30%
Beta
0.428
Debt to Equity
56.91
Financial Highlights
Profitability
Gross Margin
57.34%
Operating Margin
34.03%
Profit Margin
18.86%
Returns and Earnings
Return on Assets (TTM)
6.50%
Return on Equity (TTM)
12.30%
EBITDA
$362.0M
Net Income (TTM)
$214.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$22.98
Quarterly Revenue Growth (YoY)
7.10%
Quarterly Earnings Growth (YoY)
1.40%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Prestige Consumer PBH | 3.79B Mid-cap | -0.90% | -13.52% | -25.39% | -23.71% | -16.38% | -5.19% | 14.08% | 74.66% |
| Zoetis ZTS | 65.30B Large-cap | 4.59% | 0.82% | -3.89% | -1.51% | -5.23% | -16.11% | -9.09% | -2.69% |
| Haleon Plc - ADR HLN | 43.57B Large-cap | 1.15% | -0.82% | -9.56% | -3.40% | 2.22% | -0.31% | 61.37% | 30.23% |
| Elanco Animal Health ELAN | 8.66B Mid-cap | 7.74% | 22.93% | 38.79% | 58.66% | 49.05% | 23.95% | 2.80% | -33.73% |
| Regencell Bioscience RGC | 6.65B Mid-cap | -6.08% | -4.23% | 24.01% | 13,020.00% | 9,992.31% | 5,863.64% | 1,443.53% | 4,585.71% |
| Alkermes plc ALKS | 4.80B Mid-cap | 8.76% | 0.69% | -6.92% | -19.08% | 1.04% | 6.61% | 15.00% | 70.18% |
Ownership & Short Interest
Insider Ownership
1.23%
Institutional Ownership
108.15%
Shares Short
2M
Short Ratio
3.44
Short % of Shares Outstanding
4.28%
Average 10-Day Volume
406K
Average 90-Day Volume
412K
Prestige Consumer Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Prestige Consumer would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PBH's 52-week high and low?
- In the last 52 weeks, Prestige Consumer reached a high of $90.04 (on March 10, 2025) and a low of $62.95 (on August 12, 2025).
- What is the market cap and P/E ratio for PBH?
- Curious about Prestige Consumer's size and valuation? Its market capitalization stands at 3.79B. When it comes to valuation, the P/E ratio (trailing twelve months) is 17.92, and the forward P/E (looking ahead) is 16.12.
- Does PBH pay dividends? If so, what's the yield?
- As for dividends, Prestige Consumer isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Prestige Consumer's main competitors or similar companies to consider before investing?
When looking at Prestige Consumer, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Zoetis
ZTS65.30B Healthcare Drug Manufacturers - Specialty & Generic -16.11% -9.09% Haleon Plc - ADR
HLN43.57B Healthcare Drug Manufacturers - Specialty & Generic -0.31% 61.37% Elanco Animal Health
ELAN8.66B Healthcare Drug Manufacturers - Specialty & Generic 23.95% 2.80% Regencell Bioscience
RGC6.65B Healthcare Drug Manufacturers - Specialty & Generic 5,863.64% 1,443.53% Alkermes plc
ALKS4.80B Healthcare Drug Manufacturers - Specialty & Generic 6.61% 15.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Prestige Consumer Healthcare Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Prestige Consumer's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.30%, the Debt to Equity ratio from the most recent quarter is 56.91, and its Gross Profit Margin stands at 57.34%.
- What is the recent revenue and earnings growth for PBH?
- Looking at Prestige Consumer's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 7.10%, and quarterly earnings saw a YoY growth of 1.40%.
- How much of PBH stock is held by insiders and institutions?
- Wondering who owns Prestige Consumer stock? Company insiders (like executives and directors) hold about 1.23% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 108.15%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.